Aprotinin improves hemostasis after cardiopulmonary bypass better than single-donor platelet concentrate
Authors:
- Douglas ZippelDZDouglas Zippel
- Jacob LaveeJLJacob Lavee
- Ayala LuskyALAyala Lusky
- Eilat ShinarESEilat Shinar
- Naphtali SavionNaphtali Savion
- Rephael MohrRMRephael Mohr
- 1 April 1995
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 59 (4) , 872-876
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Aprotinin in perspectiveThe Annals of Thoracic Surgery, 1993
- Storage and transfusion of platelets collected by an automated two‐ stage apheresis procedureTransfusion, 1992
- Platelet protection by aprotinin in cardiopulmonary bypass: Electron microscopic studyThe Annals of Thoracic Surgery, 1992
- Platelet Activation and Aggregation during Cardiopulmonary BypassAnesthesiology, 1991
- Temperature dependence of plasmin-induced activation or inhibition of human plateletsBlood, 1991
- Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial RevascularizationAnesthesiology, 1990
- Bleeding complications associated with cardiopulmonary bypassBlood, 1990
- Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors.Journal of Clinical Investigation, 1990
- The effect of transfusion of fresh whole blood versus platelet concentrates after cardiac operationsThe Journal of Thoracic and Cardiovascular Surgery, 1989
- Platelet preservation during cardiopulmonary bypass with aprotininEuropean Journal of Cardio-Thoracic Surgery, 1989